Latest news
aTyr Pharma Prioritizes Efzofitimod Program, Cuts Workforce 60% as FDA Feedback on Phase 3 Sarcoidosis Study Protocol Looms - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 20:10:00 GMTAs I decipher ongoing liver issues, at least my treasured coffee is good for me - Sarcoidosis NewsSarcoidosis News · Fri, 07 Aug 2026 19:36:31 GMTNamilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis - HCPLiveHCPLive · Fri, 07 Aug 2026 14:06:13 GMTFSR Invests $700,000 Across Four Sarcoidosis Studies to Improve Diagnosis, Monitoring, and Patient Outcomes - BioSpaceBioSpace · Wed, 05 Aug 2026 02:34:40 GMTStudy links manual work to higher risk of sarcoidosis - Sarcoidosis NewsSarcoidosis News · Wed, 05 Aug 2026 01:07:15 GMTHepatic sarcoidosis presenting with portal hypertension without histologically established cirrhosis and reticular hepatic imaging features - Springer Nature LinkSpringer Nature Link · Tue, 04 Aug 2026 07:00:00 GMT